Navigation Links
NJIT to host major biomedical engineering showcase and career fair
Date:2/18/2009

More than 300 people and 30 companies are expected to attend the sixth annual biomedical engineering showcase and career fair on March 13, 2009 at NJIT. The annual event, to be held from 7: 30 a.m.- 3:30 p.m. in NJIT's Campus Center, unites industry professionals and academics interested in the applied-life sciences.

"Explore the Leading Edge of the Biomedical Frontier: Neuro-engineering, Imaging and Assistive Technologies" will feature keynote presentations and panel discussions with academic and industrial leaders. A display of student research projects will highlight the event. The showcase provides a forum to discuss key scientific and business issues of interest to the biotechnology, medical device and pharmaceutical industries.

"Bringing people together in one setting is essential," said Judith Sheft, associate vice president technology development at NJIT. "Building synergies among them is key to biomedical engineering and biotechnology, since both rely on interdisciplinary collaborations."

Keynote presentations will address university research in neuro-engineering and panels will discuss clinical perspectives in neurosurgery and imaging and funding for translational research. There will be a breakout session focused on student career issues such as the hiring process and career preparation in biomedical engineering.

A student career fair highlights the afternoon sessions starting at 1:30 p.m.. Students studying biomedical engineering, biotechnology and other health-science related careers will have a chance to meet prospective employers in those fields. The companies will discuss full time, co-op, internship and summer employment opportunities.

Event sponsors with NJIT are Rutgers-The State University of New Jersey; Princeton University; University of Medicine and Dentistry of New Jersey; Stevens Institute of Technology; and Kean University. Event partners with NJIT are BioNJ; New Jersey Commission on Science and Technology; New Jersey Commission on Spinal Cord Research, HealthCare Institute of New Jersey and North Jersey Partners (WIRED). Sponsorship support has been provided by the Foundation Venture Capital Group LLC; the White Rose Health Innovation Partnership; Cushman and Wakefield; Lowenstein Sandler, New Jersey Business Incubation Network, New Jersey Technology Council and Amper, Politziner and Mattia.


'/>"/>

Contact: Sheryl Weinstein
sheryl.m.weinstein@njit.edu
973-596-3436
New Jersey Institute of Technology
Source:Eurekalert

Related biology news :

1. deCODE discovers cause of major subtype of glaucoma
2. Bleeding, not inflammation, is major cause of early lung infection death
3. Mustafa alAbsi Ph.D. and national team awarded major NIH grant
4. Leading experts cite poor health and nutrition as major barrier to education in developing world
5. Majority of Americans want local action on global warming, says poll
6. How schizophrenia develops: Major clues discovered
7. Major genetic breakthrough for ankylosing spondylitis brings treatment hope
8. NIH selects LIAI for major study on allergy molecular causes and possible treatments
9. Local sources major cause of US near-ground aerosol pollution
10. Tree of life for flowering plants reveals relationships among major groups
11. Humans not the major target of Shiga toxin
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/2/2017)... JACKSONVILLE, Fla. , Feb. 2, 2017 /PRNewswire/ ... ), a clinical-stage immuno-oncology company specializing in the ... vaccines for the treatment of cancer and metastatic ... multi-gram scale-up and GMP manufacturing of a second ... T-cell vaccine targeting folate receptor alpha. The manufactured ...
(Date:1/31/2017)...  Spero Therapeutics, LLC, a biopharmaceutical company founded ... bacterial infections, today announced it has acquired a ... Bono Bio Ltd (PBB) to bolster its pipeline ... of Gram-negative bacteria.   The assets acquired have been ... group company. "The acquisition of these ...
(Date:1/25/2017)... , Jan. 25, 2017 The Elements ... Management (IAM) lifecycle is comprised of a comprehensive ... the purpose of maintaining digital identities and providing ... and applications. There are significant number of programs ... time to time by optimizing processes and changing ...
Breaking Biology News(10 mins):
(Date:2/22/2017)... 2017 Aethlon Medical, Inc. (Nasdaq: ... that validated the ability of the Aethlon Hemopurifier® to ... mortality in immune-suppressed sepsis patients and also contribute to ... objective of the study was to validate the ... (EBV) and Herpes Simplex virus 1 (HSV1) by the ...
(Date:2/22/2017)... and RESEARCH TRIANGLE PARK, N.C., Feb. 22, 2017 /PRNewswire/ ... today announced its financial results for the fourth ... "Our annual 2016 financial results reflect continued growth ... exceeded $700 million," said Martine Rothblatt, Ph.D., United ... results strengthen our ability to develop and advance ...
(Date:2/21/2017)... ... 21, 2017 , ... Vortex Biosciences announced the ... benchtop system for collecting intact circulating tumor cells (CTCs) that are shed by ... Tri Conference (Tri-Con) Annual Meeting 2017 (February 19–24 San Francisco). , The ...
(Date:2/21/2017)... IL (PRWEB) , ... February ... ... of the Life -Sciences division, Treximo will pair its $200M operational capacity ... results-based consulting and project management in areas affecting quality and operational management. ...
Breaking Biology Technology: